25238 Federal Register / Vol. 60, No. 91 / Thursday, May 11, 1995 / Notices

considered late applications. Late

applications will not be considered in

the current competition and will be

returned to the applicant.

Where To Obtain Additional

Information

Information on application

procedures, copies of application forms,

and other materials may be obtained

from Lisa Tamaroff, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Mailstop E13, Atlanta, GA 30305,

telephone (404) 842–6796.

Please refer to Announcement

Number 550 when requesting

information and submitting an

application.

Programmatic technical assistance

may be obtained from William A.

Murrain, Immunization Services

Division, National Immunization

Program, Centers for Disease Control

and Prevention (CDC), 1600 Clifton

Road, Mailstop E52, Atlanta, GA 30333,

telephone (404) 639–8208.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report; Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report;

Stock No. 017–001- 00473–1) through

the Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

Copies of the ‘‘Standards for Pediatric

Immunization Practices’’ may be

obtained from the National

Immunization Program, Immunization

Services Division, Centers for Disease

Control and Prevention (CDC), Mailstop

E–34, 1600 Clifton Road, NE., Atlanta,

GA 30333, telephone (404) 639–8225.

Dated: May 5, 1995.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 95–11624 Filed 5–10–95; 8:45 am]

BILLING CODE 4163–18–P

Injury Research Grant Review

Committee: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Injury Research Grant Review

Committee (IRGRC).

Times and Dates: 6 p.m.–9 p.m., June 4,

1995; 8 a.m.–5 p.m., June 5, 1995; 8 a.m.–12

noon, June 6, 1995.

Place: Wyndham Garden Hotel-Midtown,

125 10th Street, NE, Atlanta, Georgia 30309.

Status: Open: 6 p.m.–7 p.m., June 4, 1995;

closed: 7 p.m.–9 p.m., June 4, 1995, through

12 noon, June 6, 1995.

Purpose: This committee is charged with

advising the Secretary of Health and Human

Services, the Assistant Secretary for Health,

and the Director, CDC, regarding the

scientific merit and technical feasibility of

grant applications relating to the support of

injury control research and demonstration

projects and injury prevention research

centers.

Matters to be Discussed: Agenda items for

the meeting will include announcements,

discussion of review procedures, future

meeting dates, and review of grant

applications.

Beginning at 7 p.m., June 4, through 12

noon, June 6, the committee will meet to

conduct a review of grant applications. This

portion of the meeting will be closed to the

public in accordance with provisions set

forth in section 552b(c) (4) and (6), title 5

U.S.C., and the Determination of the

Associate Director for Management and

Operations, CDC, pursuant to Pub. L. 92–463.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Richard W. Sattin, M.D., Executive Secretary,

IRGRC, National Center for Injury Prevention

and Control, CDC, 4770 Buford Highway, NE,

Mailstop K58, Atlanta, Georgia 30341–3724,

telephone 404/488–4580.

Carolyn J. Russell,

Director, Management Analysis and Services

Officer, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–11625 Filed 5–10–95; 8:45 am]

BILLING CODE 4163–18–M

National Institutes of Health

Notice of Meeting of the Advisory

Committee to the Director, NIH

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Advisory Committee to the Director,

NIH, May 31, 1995, Conference Room

10, Building 31, National Institutes of

Health, Bethesda, Maryland 20892.

The entire meeting will be open to the

public from 10:00 a.m. to adjournment.

The topics proposed for discussion

include (1) Report on the Structure and

Function of the Division of Research

Grants; (2) Views from the NIH Basic

Research Ombudsman and the NIH

Clinical Research Emissary; (3) REGO

II—Study of the Clinical Center; and (4)

New Affirmative Action Plan.

Attendance by the public will be limited

to space available.

Ms. Janice Ramsden, Program

Assistant, Office of the Deputy Director,

National Institutes of Health, 1 Center

Drive MSC 0159, Bethesda, Maryland

20892–0159, telephone (301) 496–0959,

fax (301) 496–7451, will furnish the

meeting agenda, roster of committee

members, and substantive program

information upon request. Any

individual who requires special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Ramsden no later than May 24, 1995.

Dated May 5, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–11596 Filed 5–10–95; 8:45 am]

BILLING CODE 4140–01–M

John E. Fogarty International Center

for Advanced Study in the Health

Sciences; Meeting of the Fogarty

International Center Advisory Board

Pursuant to Pub. L. 92–463, notice is

hereby given of the thirtieth meeting of

the Fogarty International Center (FIC)

Advisory Board, May 23, 1995, in the

Lawton Chiles International House

(Building 16), at the National Institutes

of Health.

The meeting will be open to the

public from 8:30 a.m. to noon. In

addition to a report by the Director, FIC,

and a report on the Science Leadership

Exchange that was recently sponsored

by the White House Office of Science

and Technology Policy, the agenda will

focus on new and emerging infectious

diseases which result from ecological

changes and population patterns. In

addition to naturally evolving disease

pathogens, the agenda also will address

manufactured pathogens and research

issues related to biological weapons.

In accordance with the provisions of

Secs. 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. and sec. 10(d) of Pub. L. 92–463,

the meeting will be closed to the public

from 1:15 p.m. to adjournment for the

review of applications to the

International Research Fellowship and

Senior International Fellowship

Programs; Fogarty International

Research Collaboration and HIV, AIDS

and Related Illnesses Collaboration

Awards; nominations to the Scholars-inResidence Program; and proposals for

Scholar’s conferences.

Paula Cohen, Committee Management

Officer, Fogarty International Center,

National Institutes of Health, Building

31, Room B2C08, 31 CENTER DR MSC

2220, Bethesda, Maryland 20892–2220,

telephone: 301–496–1491, will provide

a summary of the meeting and a roster

of the committee members upon

request.

Irene Edwards, Executive Secretary,

Fogarty International Center Advisory

Board, Building 31, Room B2C08,

telephone: 301–496–1491, will provide

substantive program information.